ASSESSMENT OF SURROGATE MARKERS FOR CARDIOVASCULAR DISEASE IN FAMILIAL MEDITERRANEAN FEVER-RELATED AMYLOIDOSIS PATIENTS HOMOZYGOUS FOR M694V MUTATION IN MEFV GENE

Simple item page
dc.contributor.authorSahin, Sezgin
dc.contributor.authorRomano, Micol
dc.contributor.authorGuzel, Ferhat
dc.contributor.authorPiskin, David
dc.contributor.authorPoddighe, Dimitri
dc.contributor.authorSezer, Siren
dc.contributor.authorKasapcopur, Ozgur
dc.contributor.authorAppleton, C. Thomas
dc.contributor.authorYilmaz, Ilker
dc.contributor.authorDemirkaya, Erkan
dc.date.accessioned2023-04-28T10:33:33Z
dc.date.available2023-04-28T10:33:33Z
dc.date.issued2022
dc.description.abstractCardiovascular disease (CVD) remains underestimated in familial Mediterranean feverassociated AA amyloidosis (FMF-AA).We aimed to compare early markers of endothelial dysfunction and atherosclerosis in FMF-AA with a homozygous M694V mutation (Group 1 = 76 patients) in the Mediterranean fever (MEFV) gene and in patients with other genotypes (Group 2 = 93 patients). Measures of increased risk for future CVD events and endothelial dysfunction, including flowmediated dilatation (FMD), pentraxin-3 (PTX3), and carotid intima-media thickness (cIMT), and fibroblast growth factor 23 (FGF23) as a marker of atherosclerotic vascular disease were compared between groups. The frequency of clinical FMF manifestations did not differ between the two groups apart from arthritis (76.3% in Group 1 and 59.1% in Group 2, p < 0.05). FMD was significantly lower in Group 1 when compared with Group 2 (MD [95% CI]: 􀀀0.6 [(􀀀0.89)–(􀀀0.31)]). cIMT, FGF23, and PTX3 levels were higher in Group 1 (cIMT MD [95% CI]: 0.12 [0.08–0.16]; FGF23 MD [95% CI]: 12.8 [5.9–19.6]; PTX3 MD [95% CI]: 13.3 [8.9–17.5]). In patients with FMF-AA, M694V homozygosity is associated with lower FMD values and higher cIMT, FGF23, and PTX3 levels, suggesting increased CVD risk profiles. These data suggest that a genotype–phenotype association exists in terms of endothelial dysfunction and atherosclerosis in patients with FMF-AA.en_US
dc.identifier.citationSahin, S., Romano, M., Guzel, F., Piskin, D., Poddighe, D., Sezer, S., Kasapcopur, O., Appleton, C. T. G., Yilmaz, I., & Demirkaya, E. (2022). Assessment of Surrogate Markers for Cardiovascular Disease in Familial Mediterranean Fever-Related Amyloidosis Patients Homozygous for M694V Mutation in MEFV Gene. Life, 12(5), 631. https://doi.org/10.3390/life12050631en_US
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/7045
dc.language.isoenen_US
dc.publisherLifeen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/us/*
dc.subjectType of access: Open Accessen_US
dc.subjectfamilial Mediterranean feveren_US
dc.subjectM694V homozygosityen_US
dc.subjectAA amyloidosisen_US
dc.subjectcardiovascular diseaseen_US
dc.subjectflow-mediated dilatationen_US
dc.subjectcarotid artery intima-media thicknessen_US
dc.titleASSESSMENT OF SURROGATE MARKERS FOR CARDIOVASCULAR DISEASE IN FAMILIAL MEDITERRANEAN FEVER-RELATED AMYLOIDOSIS PATIENTS HOMOZYGOUS FOR M694V MUTATION IN MEFV GENEen_US
dc.typeArticleen_US
workflow.import.sourcescience

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
life-12-00631.pdf
Size:
972.13 KB
Format:
Adobe Portable Document Format
Description:
article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
6.28 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Articles